Table 2.

Demographic characteristics and outcome among four diagnostic categories of HV infection and non-HV disease

Demographic	HF	Mild HPS group A	Mild HPS group B	Moderate to severe HPS	HV-negative	Leptospirosis
N	52	25	27	13	27	6
Male (%)	55.8	52.0	59.3	61.5	63.0	83.3
Age (years) mean (SD); range	33.7 (16.3); 11–79	33.1 (17.5); 13–64	38 (14.0); 11–67	38 (20.5); 17–78	30.7 (14.7); 4–61	21 (13.5); 7–41
Clinic*	34/12/6	18/7/0	10/17/0	2/5/6	9/12/6	3/1/2
Hospitalized (%)	61.5	80.0	100.0	100.0	37.0	66.7
Days of hospitalization†	4.2, 1–9	5.4, 1–12	7.2, 1–18	9.3, 1–42	3.0, 1–8	3.0, 2–4
Days of symptoms†	7.6, 2–16	8.0, 1–25	11.4, 6–26	13.2, 2–46	6.2, 2–14	5.6, 3–7
Days of fever PTH†	4.1, 0–9	3.3, 0–13	4.1, 2–8	5.4, 2–15	3.6, 0–14	4.3, 3–7
Death (%)‡	0.0 (0)	0.0 (0)	0.0 (0)	53.8 (7)	0.0 (0)	16.7 (1)

HV-negative = negative for HV infection and leptospira infection; mild HPS group A, mild HV pulmonary syndrome without hypoxemia or dyspnea; PTH = prior to hospitalization.

^*Distribution among clinics: Tonosí/Soná/Aguadulce and Natá.

^†Days (mean, range); PTH before hospitalization.

^‡Three patients died in the first 24 hours.